The obstructive sleep apnea (OSA) market is being propelled by the rapid evolution of early detection and diagnostic tools. Technologies like home sleep apnea testing (HSAT), AI-powered applications, ...

Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, ...

ICMR and Panacea Biotec conduct third phase trials for indigenous dengue vaccine in India with promising results.

Chandigarh: The PGI is at the forefront of India's efforts to develop indigenous solid tumour cancer drugs, serving as one of the four pivotal Phase 1.

A recent study found that only 15% of cancer survivors discussed trials with their healthcare providers, with ...

Epitopea expands clinical development and research capabilities; forms research & clinical teams as it speeds up to clinical operations: Cambridge, UK Saturday, July 12, 2025, 16: ...

Multifaceted Mechanisms and Future of Diabetic Wound Healing and the rapidly evolving subject area, we are pleased to ...

The global clinical trials market is anticipated to grow at a CAGR of 6-7% from 2024 to 2029. This growth is driven by the increasing demand for personalized medicines, expansion in clinical research ...

How the application of artificial intelligence, broader use of real-world evidence, decentralized clinical trials, master protocols, and risk-based quality monitoring, together with strong ethical ...

Considering a migraine clinical trial? Learn about the types, benefits, risks, and eligibility, along with what questions you should ask to see if participating is right for you.

US$ 190 Billion By 2030. Insight On FDA Designated Orphan Drugs In Clinical Trials: > 850 Orphan Drugs. Clinical Trials ...